Thursday, May 09 2024
08:52 AM – 09:18 AM ET - Room 339-342
Antisense oligonucleotide neonatal therapy for osteogenesis imperfecta
Liubin Yang - PHD,MD
Baylor College of Medicine
Disclosures: L. Yang: 1; Commercial Interest i.e. Company X; Prolacta Biosciences. 1; What was received? i.e. Honorarium; Consulting fee. 1; For what role? i.e. Speaker; Consulting.